October 24, 2015 FDA approves hepatitis C drug that costs $1,125 per pill Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.
October 24, 2015 Patient taking Novartis multiple sclerosis pill developed rare disease A patient taking Novartis' multiple sclerosis pill Gilenya developed a rare and potentially fatal viral disease, the Swiss drugmaker said on Tuesday, an unexpected setback as it faces growing competition from new oral treatments.
October 24, 2015 Is fish oil safe during chemotherapy? Fish oil supplements might make cancer chemotherapy less effective - but many people with cancer were taking those supplements in a recent survey.
October 24, 2015 Fake medicines worth $31 million seized in global crackdown Law enforcement agents have arrested 237 people worldwide in a 10-day crackdown on fake drugs, resulting in the seizure of counterfeit and unlicensed medicines worth 18.6 million pounds ($31.4 million), Britain's healthcare watchdog said.
October 24, 2015 FDA approves third of new drugs after one clinical trial About one-third of new drugs introduced in the U.S. from 2005 to 2012 were approved by government regulators on the basis of a single large clinical trial, according to a new study.
October 24, 2015 Prescription painkiller deaths up 261 percent in NYC New York City health officials say deaths from prescription painkillers such as Oxycontin and Vicodin increased 261% between 2005 and 2011.
October 24, 2015 FDA wants restrictions on hydrocodone painkillers The Food and Drug Administration is recommending new restrictions on prescription medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
October 24, 2015 Rare side effect of Tylenol causes burns to woman's body An Indiana woman was feeling sick during a vacation, took Tylenol, and ended up with burns to 40 percent of her body as a side effect, WSMV reported.
October 24, 2015 FDA panel votes to remove long-used osteoporosis drug over cancer risk A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer
October 24, 2015 FDA review of new drug for smoking-related lung damage seen as positive An experimental treatment for smoking-related lung damage received a better-than-expected initial review from the U.S. Food and Drug Administration, potentially paving the way for a recommendation in favor of approval when an outside panel of experts meets to review the drug later this week.
